February 1982
Volume 22, Issue 2
Free
Articles  |   February 1982
Galactose cataract prevention with sorbinil, an aldose reductase inhibitor: a light microscopic study.
Investigative Ophthalmology & Visual Science February 1982, Vol.22, 174-179. doi:https://doi.org/
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M Datiles, H Fukui, T Kuwabara, J H Kinoshita; Galactose cataract prevention with sorbinil, an aldose reductase inhibitor: a light microscopic study.. Invest. Ophthalmol. Vis. Sci. 1982;22(2):174-179. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
This content is PDF only. Please click on the PDF icon to access.
Abstract

Cataract formation in galactosemic rats was studied by ophthalmoscopy, slit-lamp biomicroscopy, and by light microscopy using plastic embedding with methacrylate. Untreated rats developed nuclear cataracts by 14 days and mature cataracts by 21 days. However, rats treated with the aldose reductase inhibitor sorbinil did not develop any cataractous change for up to 8 months of 50% galactose feeding and could not be distinguished from normal controls. This strongly suggests that aldose reductase is the common factor involved in the formation of sugar cataracts.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×